by
Complex regional pain syndrome (CRPS), also known as reflex sympathetic dystrophy syndrome (RSD), is a chronic pain condition that usually affects an arm or leg after an injury. CRPS most often impacts one limb such as an arm, hand, leg, or foot. It causes severe burning pain, swelling, changes in skin color and temperature, and impaired functioning in the affected limb. Patients often experience intense pain that seems disproportionate to the severity of the initial injury or event. CRPS usually develops after an injury, a surgery, a stroke or a heart attack. Some common causes of CRPS include limb fractures, sprains, bruises or nerve injuries.
The global Complex Regional Pain Syndrome Market is estimated to be valued at US$ 119.47 Mn in 2023 and is expected to exhibit a CAGR of 7.2% over the forecast period from 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
The global Complex Regional Pain Syndrome market is driven by increasing awareness about the condition and availability of effective treatment options. Advanced diagnostic techniques are enabling early diagnosis and management of CRPS. Growing geriatric population who are more prone to CRPS due to age-related injuries and medical conditions is also boosting market growth. However, lack of awareness in developing regions continues to limit full market potential.
Market Dynamics:
Complex Regional Pain Syndrome Market Expected to Gain Traction driven by Increasing Awareness and Diagnosis Rates” refers to two key drivers – increasing awareness and diagnosis rates. Higher awareness about symptoms and risk factors of CRPS among general population as well as physicians is leading to more accurate and timely diagnosis of the condition. Several education campaigns by healthcare organizations and patient advocacy groups in developed markets are elevating awareness. Moreover, availability of diagnostic tests helps in early detection and differentiation of CRPS from other chronic pain conditions. Advanced imaging techniques like triple phase bone scintigraphy and thermography allow physicians to positively identify signs and confirm diagnosis of CRPS. Once diagnosed, patients can be promptly treated to prevent advancement of the syndrome. Together, growing awareness and enhanced diagnostic capabilities are majorly fueling the complex regional pain syndrome market growth during the forecast period.
Segment Analysis
The complex regional pain syndrome market can be segmented into type, treatment, end-user and geography. Based on type, the market is divided into type I and type II. Type I dominates the market as it accounts for over 80% of total CRPS cases due to the involvement of small sensory nerves. By treatment, the market is classified into medications, physical therapy, occupational therapy, psychotherapy, spinal cord stimulation and others. Medications hold the largest share as drugs like neuropathic pain medications and anti-seizure medications are the first line of treatment for CRPS. On the basis of end-user, the market is bifurcated into hospitals and clinics, rehabilitation centers and others. Hospitals and clinics dominate the segment owing to availability of advanced treatment options.
PEST Analysis
Political: Government initiatives to spread awareness about complex regional pain syndrome and availability of reimbursement for its treatment are driving market growth. However, stringent regulations for new drug approvals can hamper market development.
Economic: Rising healthcare expenditure has positively impacted the market. However, high treatment costs of CRPS can restrain market growth inprice sensitive regions.
Social: Increasing prevalence of chronic pain disorders and growing geriatric population who are more prone to CRPS are fueling market demand.
Technological: Advancements in treatment technologies like spinal cord stimulation systems have provided improved outcomes. Development of novel drug delivery methods can expand the market size during the forecast period.
Key Takeaways
Global Complex Regional Pain Syndrome Market Size is expected to witness high growth at a CAGR of 7.2% during the forecast period. The global Complex Regional Pain Syndrome Market is estimated to be valued at US$ 119.47 Mn in 2023 and is expected to exhibit a CAGR of 7.2% over the forecast period from 2024 to 2031.
Regional analysis indicates North America dominates the market currently due to high awareness and well-developed healthcare infrastructure in the region. Europe holds the second largest share.
Key players operating in the complex regional pain syndrome market are Intercos S.p.A., Kolmar Korea Co. Ltd., Scalpi Cosmética sa, Cosmecca Korea Co., Cosmax Inc., Mana Products Inc., KBL cosmetics Ltd., Urist Cosmetics Incorporated, Fareva Holding SA, Milliona Cosmetics Co., Ltd., Skinlys, Maesa SAS, Schwanhäußer Holding GmbH & Co. KG, Tricorbraun Inc., Herrco Cosmetics Limited, Architectural Beauty, Allure Labs Inc., Case Mason Filling, Inc., Pardaco Trading Pte Ltd, and KDC/ONE among others. Intercos S.p.A., Cosmecca Korea Co., and Kolmar Korea Co. Ltd. are identified as the major players due to their innovative product portfolio and extensive geographical presence.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
